Clinical Trial: Safety and Efficacy Study of Flebogamma 5% DIF IGIV in Pediatric Subjects

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional




Official Title: Evaluation of the Efficacy and Safety of Flebogamma 5% DIF [Immune Globulin Intravenous (Human)] for Replacement Therapy in Pediatric Subjects With Primary Immunodeficiency Diseases.

Brief Summary: This is a multi-center, open-label study to assess the efficacy and safety of Flebogamma 5% DIF in the pediatric population.